Summary

Other Scenarios:

Buyer: Baxter International Inc. (BAX) Last Price: 48.75 Market Cap.: 31.90B
Target: Angiotech Pharmaceuticals, Inc. (USA) (ANPI) Last Price: 8.82 Market Cap.: 749.56M

Lines of Business Summary:

Product Summary:

Overlap & Complementary Sectors

Sector Buyer Target # of Focused Companies
*Healthcare 865
Biopharmaceuticals 326
Healthcare Services   156
Medical Devices 247
Nutritional Health   22
Outsourced Services   67
Scientific Products   40

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Sample Products in Similar Lines of Business

Sample Products in Complementary Lines of Business
Buyer (Total: 205)
  • Physiometrix Patient State Analyzer (PSA) 4000
  • Ultra-Seal Anesthesia Face Mask Series
  • Baxter Breathing Bag Series
  • Ultra-Fit Anesthesia Face Mask Series
Target (Total: 23)
  • COOK V-Flex Plus Paclitaxel-Eluting Coronary Stents
  • TAXUS Liberte (Paclitaxel-Eluting Coronary Stent)
  • PETAL (Paclitaxel Eluting Bifurcated Stent)
  • COOK Paclitaxel-Coated Coronary Stent
Buyer
  • Phenergan (Promethazine)
  • Diphenhydramine
  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
Target
  • PAXCEED (Paclitaxel)
  • Cohesion Technologies Cell Prime Collagen In Solution
  • Cohesion Technologies Vitrogen, Collagen In Solution

Business Relationship Summary:

Top Key Suppliers

Top Key Customers
Buyer (Total: 15)
  • Teva Pharmaceutical Industries Ltd (ADR) (TEVA)
  • Acxiom Corporation (ACXM)
  • TALX Corporation (TALX)
  • Angiotech Pharmaceuticals, Inc. (USA) (ANPI)
Target (Total: 1)
  • Orthovita Inc. (VITA)
Buyer (Total: 14)
  • Medco Health Solutions Inc. (MHS)
  • MedImmune, Inc. (MEDI)
  • DaVita Inc. (DVA)
  • Amylin Pharmaceuticals, Inc. (AMLN)
Target (Total: 1)
  • Baxter International Inc. (BAX)

Key Financial Summary:

Key Metrics

  Buyer Target
Number of Employees 47,000 215
Revenue Per Employee 218,214.9 1,647,772.0
Total Revenue 2,763.0 86.3
Total Expenses 2,241.0 69.8
Other Revenue 0.0 0.0
Cost of Revenue 1,448.0 27.9
SG&A Expense 612.0 19.1
Research & Development 181.0 11.7
Other Operating Expense 0.0 0.0
Operating Income 522.0 16.5
Unusual Income 0.0 1.9
LT Debt to Capital 29.04 53.87
Fwd P/E 22.76 14.77
Fwd P/Rev 3.14 2.45
Book Value 6,272.0 485.3
Curr Portion of LTD/Cap Lease 0.0 3.2

Individual Company Summary

Focused

Buyer

Focused (): *Healthcare > Medical Devices

Target

Focused (): *Healthcare > Medical Devices > Cardiology > Surgical

Business Description

Buyer

Baxter International Inc. (Baxter) assists healthcare professionals and their patients with the treatment of complex medical conditions, including hemophilia, immune disorders, infectious diseases, cancer, kidney disease, trauma and other conditions. Baxter's products are used by hospitals, clinical and medical research laboratories, blood and plasma collection centers, kidney dialysis centers, rehabilitation centers, nursing homes, doctors' offices and by patients at home under physician supervision. The Medication Delivery, BioScience and Renal segments comprise Baxter's operations. The Company manufactures products in 28 countries and sells them in over 100 countries.

Target

Angiotech Pharmaceuticals, Inc. (Angiotech) is a specialty pharmaceutical company focused on developing and commercializing technologies that improve the performance of medical devices and the outcomes of surgical procedures. The Company's first commercial product is a paclitaxel-eluting coronary stent system for the treatment of coronary artery disease. This product was developed based on the discovery that the drug paclitaxel blocks a cellular pathway involved in scar formation. The TAXUS paclitaxel-eluting coronary stent incorporates Angiotech's technology, and is sold by its partner Boston Scientific Corporation (BSC). On March 23, 2006, it completed the acquisition of American Medical Instruments Holding Inc. (AMI). The Company completed the acquisition of Quill Medical, Inc., including all of its technology and intellectual property in June 2006.

Deal Summary

Key Ratios

  Buyer Target
Gross Margin % 45.64 72.48
Operating Margin % 17.74 0.15
Quick Ratio 1.2 1.74
Current Ratio 1.93 2.63
Coverage Ratio -0.02 -53.61
Total Assets 14,686.0 1,194.4
Return on Equity % 22.29 -5.05
Return on Assets % 9.52 -2.05
Cash+ ST Inv. Per Share 3.79 1.05
Total Debt 2,801.0 569.9
Total Debt to Equity % 44.66 117.44
Total Debt to Tangible Equity % 44.66 n/a
Debt to Asset % 19.07 47.71

Product Summary

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies
The Allergies Subsector includes therapeutics that treat exaggerated immune reaction induced by exposure to a foreign substance.
  
Cardiovascular System
The Cardiovascular System Subsector includes therapeutics that treat disorders affecting the heart and blood vessels.
  
Dermatology
The Dermatology Subsector includes therapeutics that treat disorders affecting the skin.
  
Digestive System
The Digestive System Subsector includes therapeutics that treat disorders affecting the digestive system.
  
Hematology
The Hematology Subsector includes therapeutics that treat blood-based diseases and disorders.
  
Immunology
The Immunology Subsector includes therapeutics that treat disorders affecting the immune system.
Infectious Diseases
The Infectious Diseases Subsector includes therapeutics that treat diseases caused by the invasion and reproduction of microorganisms in the body.
  
Musculoskeletal System
The Musculoskeletal System Subsector includes therapeutics that treat disorders of the bones, joints, ligaments, tendons, and soft tissue involved with them.
Neurology
The Neurology Subsector includes therapeutics that treat disorders of the central nervous system, including the brain, spinal cord, and nerves.
  
Oncology
The Oncology Subsector includes therapeutics that treat and manage various types of cancer and related complications.
  
Pain Management
The Pain Management Subsector includes therapeutics that treat and management pain.
  
Respiratory System
The Respiratory System Subsector includes therapeutics that treat disorders affecting both the upper and lower respiratory tract, including the nose, throat, larynx, trachea, bronchi, and lungs.
  
Surgery
The Surgery Subsector includes therapeutics that treat complications associated with surgical procedures.
  
Toxicology
The Toxicology Subsector includes therapeutics that treat harmful effects from exposure to toxic substances; narcotics, nicotine and alcohol withdrawal therapeutics are also included in this sector.
  
Urology
The Urology Subsector includes therapeutics that treat diseases of the kidney, urinary tract, bladder, and the male reproductive system.
  
Healthcare Services  
Patient Care
The Patient Care Subsector is comprised of companies that provide services to patients for the diagnosis, treatment, and/or prevention of diseases and injuries.
  
Medical Devices
Anesthesiology
The Anesthesiology Subsector includes medical devices that deliver and monitor anesthetics.
  
Cardiology
The Cardiology Subsector includes medical devices that diagnose, monitor, and treat diseases affecting the heart and proximal blood vessels. Common devices include vital sign monitors, cardiac defibrillators, pacemakers, and other surgical equipment.
Drug Delivery
The Drug Delivery Subsector includes medical devices that facilitate the delivery of medications through different anatomical entryways, including blood vessels, skin, the mouth, and the lungs. Common devices in this sector include vascular access catheters, needles, implants, and inhalers.
Gastroenterology
The Gastroenterology Subsector includes medical devices that diagnosis and treat conditions affecting the stomach and intestinal tract.
  
General Surgery
The General Surgery Subsector includes medical devices that perform general, non-specialty surgeries; these devices are often general in scope and are used in procedures involving various parts of the body.
Medical Supplies
The Medical Supplies Subsector includes basic and consumable products that are widely used in healthcare settings.
  
Neurology
The Neurology Subsector includes medical devices that diagnose, monitor and treat neurological disorders.
  
Ophthalmology
The Ophthalmology Subsector includes medical devices that diagnose and treat eye disorders.
  
Orthopedics
The Orthopedics Subsector includes medical devices that diagnose and treat musculoskeletal diseases involving muscles, bones and joints.
Plastic/Reconstructive Surgery
The Plastic/Reconstructive Surgery Subsector includes medical devices that treat and modify a patient's external appearance.
  
Respiratory
The Respiratory Subsector includes medical devices that diagnose and treat respiratory diseases.
  
Transfusion Medicine
The Transfusion Medicine Subsector includes medical devices and accessories that prepare or implement blood transfusion.
Urology
The Urology Subsector includes medical that diagnose and treat urinary tract and male reproductive disorders.
Vascular
The Vascular Subsector includes medical devices that diagnose and treat of conditions affecting the blood vessels.
Nutritional Health  
Dietary/Naturopathic Supplements
The Dietary/Naturopathic Subsector includes nutritional biochemicals and nutrients derived from natural sources that are intended to support health.
  
Outsourced Services  
Development/Manufacturing Services
The Development/Manufacturing Services Subsector includes companies that provide research, development, manufacturing, sales and marketing to biopharmaceutical and medical device companies.
  
Scientific Products  
Consumables
The Consumables Subsector includes chemicals, reagents, standards, media, and disposable labware that are normally depleted or worn out by continuous use.
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Product Details

Sector Buyer Target
*Healthcare
Biopharmaceuticals
Allergies  
Dermatology  
Antihistamines
Products that inhibit inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Phenergan (Promethazine)
  
Ophthalmology  
Antihistamines
Therapeutics that inhibit inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Phenergan (Promethazine)
  
Upper Respiratory  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Diphenhydramine
  • Phenergan (Promethazine)
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Phenergan VC (Promethazine Hydrochloride/Phenylephrine Hydrochloride)
  • Promethazine Hydrochloride/Phenylephrine Hydrochloride
  
Cardiovascular System  
Heart Disorders  
Angina  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat chest pains by inhibiting stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol Hydrochloride
  • Atenolol
  
Arrhythmia  
Adenosine A1 Receptor Agonists
Therapeutics that treat abnormal rhythm of the heart beat by selectively stimulating the A1 adenosine receptor, slowing the speed of AV nodal conduction

Buyer Products:

  • Adenosine
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat abnormal rhythm of the heart beat by inhibiting the stimulation of beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol Hydrochloride
  • Baxter BioScience Brevibloc (Esmolol HCl)
  • Acebutalol Hydrochloride
  
Potassium Channel Blocking Agents
Therapeutics that treat abnormal rhythm of the heart by preventing the entry of potassium into heart muscle cells.

Buyer Products:

  • Quinidine Sulfate ER
  
Myocardial Infarction (MI)  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat irreversible damage to the heart muscle by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Atenolol
  • Propranolol Hydrochloride
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of heart and circulatory system disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • CD34+ Cells (Adult Stem Cells)
  
Vascular Disorders  
Hypertension  
Alpha Adrenergic Receptor Agonists
Therapeutics that treat high blood pressure by stimulating the alpha adrenergic receptors of the heart muscle.

Buyer Products:

  • Guanfacine
  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat high blood pressure by blocking the beta adrenergic receptors of the heart muscle.

Buyer Products:

  • Propranolol Hydrochloride
  • Acebutalol Hydrochloride
  • Atenolol
  
Hypovolemia  
Plasma Volumizers  
Albumin-Based
Therapeutics based on plasma proteins that treat a decrease in circulating fluid (plasma) in the body by increasing plasma volume.

Buyer Products:

  • Baxter BioScience Flexbumin (Albumin)
  • Baxter BioScience Buminate (Albumin)
  
Thromboembolism  
Anticoagulating Agents (Anticoagulants)  
Platelet Aggregation Inhibitors  
Phosphodiesterase Inhibitors
Therapeutics that treat the obstruction of a blood vessel by preventing platelets from clumping together.

Buyer Products:

  • Dipyridamole
  
Dermatology  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of skin disorders in early stages of clinical research where human subject is involved.

Target Products:

  • PAXCEED (Paclitaxel)
  
Digestive System  
Gastrointestinal Tract Disorders  
Gastroesophageal Disorders  
Gastroesophageal Reflux Disease (GERD)  
Dopamine Receptor Blocking Agents
Therapeutics that treat Gastroesophageal Reflux Disease (GERD) by blocking dopamine receptor and stimulating gastrointestinal movement without stimulating secretions from the pancreas, stomach or gall bladder.

Buyer Products:

  • Metoclopramide Hydrochloride
  
Nausea/Vomiting  
Serotonin Receptor Antagonists
Therapeutics that treat nausea and vomiting by blocking the serotonin receptors.

Buyer Products:

  • Ondansetron Injection
  • Granisetron Hydrochloride
  
Hematology  
Hemophilia  
Hemophilia A  
Clotting Agents
Therapeutics that aid in blood coagulation.

Buyer Products:

  • Baxter BioScience FEIBA VH (Immuno Anti-Inhibitor Coagulant Complex)
  • Baxter BioScience Advate/Ultra-High Dosage ADVATE (Antihemophilic Factor VIII, Plasma/Albumin Free Method (rAHF-PFM))
  • Baxter BioScience Hemofil M (Antihemophilic Factor (Human))
  
Hemophilia B  
Clotting Agents
Therapeutics that assist in blood coagulation.

Buyer Products:

  • Baxter BioScience Proplex T (Factor IX Complex)
  • Baxter BioScience FEIBA VH (Immuno Anti-Inhibitor Coagulant Complex)
  
Red Blood Cell (RBC) Disorders  
Anemia  
Recombinant Human Erythropoietins
Therapeutics that treat conditions characterized by reduced delivery of oxygen to body tissues by stimulating red blood cell production.

Buyer Products:

  • Baxter BioScience Epoetin Omega
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of hematological disorders in very early stages of research where no human subject is involved.

Buyer Products:

  • Baxter Healthcare Recombinant Factor VIII (Von Willebrand Factor (VWF)) Therapeutic Progarm
  
Serum Factor Disorders  
Hypoalbuminemia  
Albumin-Based
Therapeutics based on plasma proteins that treat low levels of serum albumin.

Buyer Products:

  • Baxter BioScience Flexbumin (Albumin)
  • Baxter BioScience Albumin
  • Baxter BioScience Buminate (Albumin)
  
Immunology
Autoimmune Disorders  
Arthritis  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Buyer Products:

  • Etodolac
  
Idiopathic Thrombocytopenia Purpura (ITP)  
Immunoglobulins
Therapeutics that treat a decrease in platelets by neutralizing autoantibodies with therapeutic antibodies.

Buyer Products:

  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  • Baxter BioScience WinRho SDF (Rho Immunoglobulin Lyophilized/Liquid Form)
  • Baxter BioScience IVEEGAM EN/Gamimune N (Immune Globulin)
  • Baxter BioScience IVEEGAM (Immune Globulin)
  
Kawasaki Syndrome  
Immunoglobulins
Therapeutics that treat Kawasaki Syndrome by neutralizing autoantibodies with therapeutic antibodies.

Buyer Products:

  • Baxter BioScience IVEEGAM EN/Gamimune N (Immune Globulin)
  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  • Baxter BioScience IVEEGAM (Immune Globulin)
  
Immune Deficiency Disorders  
Primary Immunodeficiency Diseases  
Immunoglobulins
Therapeutics that treat primary immunodeficiency diseases by providing the body with therapeutic antibodies.

Buyer Products:

  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  • Baxter BioScience GAMMAGARD Liquid 10% (Immune Globulin Intravenous Human)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of immune disorders in early stages of clinical research where human subject is involved.

Target Products:

  • PAXCEED (Paclitaxel)
  
Infectious Diseases  
Bacterial  
Antibacterial Agents  
Broad Spectrum  
Antibiotics  
Cephalosporin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis.

Buyer Products:

  • Ceftriaxone Sodium
  
Penicillin Derivatives
Therapeutics that treat a wide variety of infections by inhibiting bacterial cell wall synthesis during active multiplication.

Buyer Products:

  • Bactocill
  
Tetracyclines
Therapeutics that treat a wide variety of infections by inhibiting protein synthesis and also causing alterations in cytoplasmic membranes.

Buyer Products:

  • Minocycline Hydrochloride
  
Narrow Spectrum  
Respiratory System  
Bronchitis  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections leading to inflammation of the bronchi in the lungs by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Pneumonia  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat inflammation of the lungs caused by bacterial infection by inhibiting folic acid synthesis and bacterial growth.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Tuberculosis  
Antitubercular Agents
Therapeutics that treat a bacterial infection of the lung by inhibiting bacterial and mycobacterial RNA synthesis.

Buyer Products:

  • Pyrazinamide
  
Urology  
Urinary Tract Infections (UTI)  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections of the urinary tract by inhibiting dihydrofolate reductase resulting in decreased bacterial nucleic acid/protein production.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Vaccines  
Bacterial  
Combination  
Diphtheria/Tetanus/Acellular Pertussis (DTaP)
Therapeutics that prevent or treat infectious disease by producing or artificially increasing immunity to pathogens that cause diphtheria, tetanus, and acellular pertussis.

Buyer Products:

  • Baxter BioScience Certiva (DTaP)
  
Mycological (Fungal)  
Antifungal Agents  
Narrow Spectrum  
Dermatology  
Tinea Barbae  
Penicillin Derivatives
Therapeutics that treat fungal infections of the bearded area by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Capitis  
Penicillin Derivatives
Therapeutics that treat fungal infections of the scalp by inhibiting biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Corporis (Ringworm)  
Penicillin Derivatives
Therapeutics that treat fungal infections of the skin characterized by scaly, red rings by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Cruris (Jock Itch)  
Penicillin Derivatives
Therapeutics that treat fungal infections of the groin and perineum by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Pedis  
Penicillin Derivatives
Therapeutics that treat fungal infections of the feet by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Unquium  
Penicillin Derivatives
Therapeutics that treat fungal infections of the nails by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Tinea Versicolor  
Penicillin Derivatives
Therapeutics that treat fungal infections of skin exposed to the sun characterized by patches of depigmentation by inhibiting the biosynthesis of cell walls.

Buyer Products:

  • Griseofulvin
  
Nervous System  
Cryptococcal Meningitis  
Triazoles
Therapeutics that treat fungal infections of lining of the brain and the spinal cord by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Otolaryngology (Ear/Nose/Throat)  
Esophageal Candidiasis  
Triazoles
Therapeutics that treat fungal infections of the esophagus caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Oropharyngeal Candidiasis  
Azoles  
Triazoles
Therapeutics that treat fungal infections of the mouth and pahrynx caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Urology  
Vaginal Candidiasis  
Azoles  
Triazoles
Therapeutics that treat fungal infections of the female reproductive organ caused by yeast by increasing permeability of the cell wall and causing a toxic build up of hydrogen peroxide.

Buyer Products:

  • Fluconazole
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in early stages of clinical research where human subject is involved.

Buyer Products:

  • Baxter BioScience Amvax (Tetanus, Diphtheria And Pertussis) Vaccine
  • Baxter BioScience Diphtheria, Tetanus, Acellular Pertussis-Inactivated Polio Virus (DTaP-IPV) Vaccine
  • H5N1 Pandemic Influenza Vaccine
  • Baxter BioScience Group C Meningococcal Vaccine
  • Baxter BioScience Haemophilus Influenzae Type B Vaccine
  • Baxter BioScience Acellular Pertussis (aP) Vaccine
  • Baxter BioScience Group B Streptococcal Vaccine
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment of infectious diseases in very early stages of research where no human subject is involved.

Buyer Products:

  • Baxter BioScience Group A/B/C Meningococcal Vaccine
  • Baxter BioScience Group A/C Meningococcal Vaccine
  • Baxter BioScience Group B Meningococcal
  • Baxter BioScience Diphtheria, Tetanus, Acellular Pertussis-Inactivated Polio Virus-Haemophilus Influenzae Type B (DTaP-IPV-HIB) Vaccine
  • Baxter BioScience Escherichia coli Vaccine
  • Baxter BioScience Pneumococcal Vaccine
  • Baxter BioScience Pneumonia (DNA Based) Vaccine
  • Baxter BioScience Diphtheria, Tetanus, Acellular Pertussis-Haemophilus Influezae Type B (DTaP-HIB) Vaccine
  • Baxter BioScience Group A Streptococcal Vaccine
  • Baxter BioScience Pneumococcal Otitis Media
  
Viral  
DNA Viruses  
Herpesvirus  
Herpes Simplex Type 1  
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurrent cold sores and fever blisters by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Herpes Simplex Type 2  
Purine Nucleoside Analogs
Therapeutics that treat viral infections characterized by recurring outbreaks of painful genital lesions by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Varicella Zoster  
Herpes Zoster (Shingles)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause shingles in adults by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Varicella (Chickenpox)  
Purine Nucleoside Analogs
Therapeutics that treat viral infections that cause chicken pox in children by inhibiting replication of viral DNA by incorporating themselves into growing viral DNA stands.

Buyer Products:

  • Acyclovir
  
Musculoskeletal System
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of skeletal system disorders in early stages of clinical research where human subject is involved.

Target Products:

  • PAXCEED (Paclitaxel)
  
Skeletal Disorders  
Joint Disorders  
Osteoarthritis (OA)  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat inflammation by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Etodolac
  
Rheumatoid Arthritis (RA)  
Analgesics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain associated with chronic inflammation of the joints by blocking cyclooxygenase activity.

Buyer Products:

  • Etodolac
  
Neurology  
Neurological Disorders  
Headaches  
Vascular (Migraine)  
Prophylactic Treatments  
Beta Adrenergic Receptor Blocking Agents (Beta Blockers)
Therapeutics that treat Migraine by inhibiting stimulation of beta adrenergic receptors.

Buyer Products:

  • Propranolol Hydrochloride
  
Neuromuscular Disorders  
Myasthenia Gravis (MG)  
Cholinesterase Inhibitors
Therapeutics that treat Myasthenia Gravis by maintaining the transmission of nerve impulses by inhibiting the enzyme that breaks down acetylcholine.

Buyer Products:

  • Baxter BioScience Enlon-Plus(R) (Edrophonium Chloride, USP & Atropine Sulfate, USP)
  • Baxter BioScience Enlon(R) (Edrophonium Chloride, USP)
  
Parkinson`s Disease (PD)  
Adjunctive Treatments  
Skeletal Muscle Relaxing Agents/Analgesics
Therapeutics that assist in the treatment of the disorder involving nerve cell loss in portions of the brain that leads to uncontrolled tremors, abnormal posture and speech problems by relaxing motor muscles and relieving pain.

Buyer Products:

  • Robaxin (Methocarbamol)
  
Psychiatric Disorders  
Anxiety  
Generalized Anxiety Disorder (GAD)  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat anxiety by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Lorazepam
  • Diazepam
  
Sleep Disorders  
Insomnia  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat insomnia by enhancing the inhibitory action of gamma-aminobutyric acid.

Buyer Products:

  • Diazepam
  
Oncology  
Hematology  
Leukemia  
Lymphoid  
Chronic  
Lymphocytic (CLL)  
Immunoglobulins
Therapeutics that treat and manage slowly progressing cancers of lymphocytic cells by providing a therapeutic protein.

Buyer Products:

  • Baxter BioScience Gammagard S/D (Immune Globulin Intravenous Solvent/Detergent)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer in early stages of clinical research where human subject is involved.

Buyer Products:

  • Leupromaxx (Sustained-Released Peptide Hormone Leuprolide Acetate)
  
Research/Preclinical Stage Products
Therapeutics that are being investigated for the treatment and management of cancer and are currently in an early research or preclinical stage of development.

Buyer Products:

  • Baxter BioScience Colon Carcinoma Vaccine
  • Baxter BioScience Small Cell Lung Carcinoma Vaccine
  • Baxter BioScience Neuroblastoma Vaccine
  
Pain Management  
Anesthesia  
General (Systemic)  
Adjunctive  
Acetylcholine Blocking Agents
Therapeutics that inhibit neuromuscular activity by competing with acetylcholine at the cholinergic receptors resulting in neuromuscular blockage.

Buyer Products:

  • Atracurium Besylate
  
Ether-Based Agents
Therapeutics that result in anesthesia due to interfering with the physiological functioning of nerve cell membranes in the brain.

Buyer Products:

  • Baxter BioScience Forane(R) (IsoFlurane, USP)
  • Baxter BioScience Suprane(R) (Desflurane, USP)
  • Baxter BioScience Ethrane(R) (Enflurane, USP)
  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that result in anesthesia by enhancing the inhibitory neurotransmitter action of gamma-aminobutyric acid.

Buyer Products:

  • Diazepam
  • Midazolam
  
Hypnotic Agents (Sedatives)
Therapeutics that result in anesthesia by inducing sleep. These therapeutics have no analgesic action.

Buyer Products:

  • Propofol
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Meperidine HCl
  • Morphine Sulfate
  • Sufentanil Citrate
  
Reversal  
Gamma-Aminobutyric Acid (GABA) Receptor Antagonists
Therapeutics that reverse general anesthesia by competitively inhibiting benzodiapizines at the GABA receptors, thus reducing their effect and reversing the anesthesia.

Buyer Products:

  • Flumazenil
  
Narcotics  
Analgesics/Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alters the both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Hydrocodone Bitartrate/Acetaminophen
  
Opioids
Therapeutics that treat pain by binding to certain nervous system receptors which alter both the perception of pain as well as the emotional response to pain.

Buyer Products:

  • Morphine Sulfate
  • Sufentanil Citrate
  
Non-Narcotics  
Non-Steroidal Anti-Inflammatory Drugs (NSAID)  
Non-Specific Cyclooxygenase Inhibitors (COX Inhibitors)
Therapeutics that treat pain by non-specifically inhibiting the action of cyclooxygenase.

Buyer Products:

  • Etodolac
  • Ketorolac Tromethamine
  
Respiratory System  
Lower Respiratory Tract Disorders (Lung Disorders)  
Bronchitis  
Complications  
Bacterial Infections  
Antibacterial Agents (Antibiotics)  
Diaminopyrimidines/Sulfonamides
Therapeutics that treat bacterial infections by inhibiting certain enzymes that are vital for bacterial DNA transcription and repair.

Buyer Products:

  • Sulfamethoxazole/Trimethoprim
  
Emphysema  
Congenital  
Proteinase Inhibitors
Therapeutics that treat emphysema by providing certain proteins. The body's lack of ability to manufacture these proteins results in the disease state.

Buyer Products:

  • Baxter Biosciences Aralast (Alpha-1 Proteinase Inhibitor)
  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of respiratory disorders in early stages of clinical research where human subject is involved.

Buyer Products:

  • Recombinant Alpha 1-Antitrypsin (AAT) Therapy
  
Upper Respiratory Tract Disorders  
Coughs/Colds  
Antihistamines
Therapeutics that inhibit the inflammation by blocking the action of histamines on tissues.

Buyer Products:

  • Diphenhydramine
  • Phenergan (Promethazine)
  
Antihistamines/Antitussives
Therapeutics that block the inflammatory action of histamines and relieve or prevent coughs.

Buyer Products:

  • Phenergan With Dextromethorphan (Promethazine Hydrochloride/Dextromethorphan Hydrochloride)
  • Promethazine Hydrochloride/Dextromethorphan Hydrochloride
  
Antihistamines/Decongestants
Therapeutics that block the inflammatory action of histamines and reduces the amount of mucous build up.

Buyer Products:

  • Phenergan VC (Promethazine Hydrochloride/Phenylephrine Hydrochloride)
  • Promethazine Hydrochloride/Phenylephrine Hydrochloride
  
Antihistamines/Decongestants/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation, preventing congestion and altering both the perception and emotional response to pain.

Buyer Products:

  • Phenergan VC With Codeine (Promethazine Hydrochloride/Phenylephrine Hydrochloride/Codeine Phosphate)
  
Antihistamines/Opioids
Therapeutics that treat coughs and colds by suppressing histamine-related inflammation and altering both the perception and emotional response to pain.

Buyer Products:

  • Phenergan With Codeine (Promethazine HCL/Codeine Phosphate)
  
Surgery  
General  
Acute Tissue Oxygen Deficiency  
Perfluorochemicals
Therapeutics that are made up mainly of carbon and fluorine that has oxygen carrying properties.

Buyer Products:

  • Baxter BioScience Oxygent(TM) (Perflubron Emulsion)
  
Complications  
Hemorrhage  
Fibrinolysis Inhibitors
Therapeutics that treat complications involving bleeding after surgical procedures by inhibiting the breakdown of fibrin in blood clots.

Buyer Products:

  • Baxter BioScience Tisseel VH Kit (Two-Component Fibrin Sealant)
  
Toxicology  
Phase I/Phase II Clinical Stage Products
Therapeutics that are being investigated for the treatment of toxicity in early stages of clinical research where human subject is involved.

Buyer Products:

  • BioScavenger (Plasma-Derived Butyrylcholinesterase)
  
Substance Abuse  
Withdrawal  
Alcohol  
Gamma-Aminobutyric Acid (GABA) Receptor Agonists
Therapeutics that treat alcohol withdrawal by increasing the effect of GABA at the relevant neuroreceptors.

Buyer Products:

  • Diazepam
  
Narcotics  
Opioid Antagonists
Therapeutics that treat narcotic addiction by blocking the effect of opioids.

Buyer Products:

  • Baxter BioScience Revex (Nalmefene HCl)
  
Urology  
Urological Disorders  
Bladder  
Cystitis  
Urotoxin Neutralizing Agents
Therapeutics that inhibit cystis induced by toxic therapeutics by neutralizing these therapeutics.

Buyer Products:

  • Mesnex (Mesna)
  
Healthcare Services  
Patient Care  
Ambulatory/Outpatient  
Specialized  
Dialysis
The process of cleansing the blood of end stage renal disease patients (ESRD) through the use of a semipermeable membrane, which allows waste products to pass but retains most of the blood's normal constituents. Dialysis services can be provided in outpatient settings, in patients' home, or in hospitals as a contractor.

Buyer Products:

  • RMS Disease Management
  • Baxter Renal Care
  • RMS Lifeline
  
Medical Devices
Anesthesiology  
Diagnostic  
Monitoring  
Systems  
Consciousness Monitoring
Systems designed to monitor the effect of anesthesia on patients during surgery.

Buyer Products:

  • Physiometrix Patient State Analyzer (PSA) 4000
  
Surgical  
General Procedure  
Delivery Systems  
Gas  
Breathing Accessories
Ancillary devices used to aid the administering of inhaled anesthetics, such as breathing bags and breathing masks.

Buyer Products:

  • Ultra-Seal Anesthesia Face Mask Series
  • Baxter Breathing Bag Series
  • Ultra-Fit Anesthesia Face Mask Series
  
Breathing Circuits
Devices which assist in physical mechanism of breathing.

Buyer Products:

  • Baxter Thick Cuff Adult Breathing Circuits
  • Thick Cuff Adult Series
  • Baxter Renal Care
  • Baxter Pediatric Isoflex Series Breathing Circuit
  • Baxter Pediatric Breathing Circuits
  • Baxter Latex-Free Breathing Circuits
  • Baxter Isoflex Series Breathing Circuits
  • Baxter Standard Adult Breathing Circuits
  
Percutaneous (Subcutaneous/Intramuscular/Intravenous)  
Fluid Administration Sets
Intravenous fluid administration sets used to deliver anesthesia.

Buyer Products:

  • Auto Syringe Pump Set Series
  • InfusO.R. Pump Set Series
  
Pumps/Systems
Devices used to pump intravenous fluids at a consistent programmed rate.

Buyer Products:

  • InfusO.R. Pump System
  • Auto Syringe Pump
  
Viscoelastics
Materials that can be applied to the skin and decrease resistance of to injected drugs.

Buyer Products:

  • Hylenex (Recombinant Human Hyaluronidase)
  
Procedure/Region Specific  
Delivery Systems  
Epidural
Devices used to inject anesthetic into the epidural space to numb the legs and abdomen, which include catheters, needles, syrninges and other prepackaged kits.

Buyer Products:

  • Continuous Double-Deck Epidural Anesthesia Tray Series
  • Double-Deck Epidural Anesthesia Tray Series
  • Continuous Single-Deck Epidural Anesthesia Tray Series
  • Single-Pack Epidural Needle Series
  • Single-Deck Epidural Anesthesia Tray Series
  
Nerve Block
Devices used to assist in the delivery of nerve block anesthetic, which include catheters, needles and other prepackaged kits.

Buyer Products:

  • Single-Deck Nerve Block Tray Series
  
Spinal
Devices used to inject anesthetic into the spine, which include catheters, needles and other prepackaged kits.

Buyer Products:

  • Single-Deck Spinal Anesthesia Tray Series
  • Single-Pack Spinal Needle Series
  • Double-Deck Spinal Anesthesia Tray Series
  
Cardiology
Surgical
General Procedure  
Accessories  
Vessel Closure
Devices used to close heart blood vessels.

Buyer Products:

  • Fusion Medical FloSeal FAST
  
Procedure/Region Specific  
Revascularization  
Percutaneous Transluminal Coronary Angioplasty (PTCA)  
Restenosis Prevention  
Stents Systems  
Coated (Drug-Eluting Stents)
Stent systems coated with pharmaceuticals that aid the stent in preventing restenosis.

Target Products:

  • COOK V-Flex Plus Paclitaxel-Eluting Coronary Stents
  • TAXUS Liberte (Paclitaxel-Eluting Coronary Stent)
  • PETAL (Paclitaxel Eluting Bifurcated Stent)
  • COOK Paclitaxel-Coated Coronary Stent
  • BSC TAXUS Express2 Paclitaxel-Eluting Coronary Stent System
  • BSC/COOK Zilver PTX Peripheral Stent
  
Drug Delivery
Infusion Therapy
Accessories  
Admixture Systems
Medical systems designed to combine multiple medications for delivery to the patients

Buyer Products:

  • Clintec Automix(R) Compounder System and Accessory
  • Clintec Micromix(R) Compounder System and Accessory
  
Closed Blood Sampling Systems
Sampling systems which do not use needles to access infusion systems to obtain a blood sample.

Buyer Products:

  • Edwards VAMP Jr.
  • Edwards VAMP
  
Filtration Products
Device used to filter fluids for infusion.

Buyer Products:

  • Fenwal Blood Device And Set Series
  • I.V. Filtration Set Series
  
Fluid Administration/Extension Sets
Filtered IV sets designed for infusion therapy.

Buyer Products:

  • Interlink Buretrol Solution Set Series
  • Interlink Catheter Extension Set Series
  • Interlink Continu-Flo Solution Set Series
  • Interlink Extension Set Series
  • Interlink Huber Needle Extension Set Series
  • High Flow Rate Extension Set
  • Interlink Secondary Medication Set Series
  • Interlink Solution Set Series
  • maxx Infusion Pump Extension Set
  • Mini-Infuser Microbore Series
  • Needle*Lock(TM) Device and Set Series
  • Interlink Minivolume Extension Set
  
Fluid Warmers
Medical devices used to maintain the warmth of the medical products prior to and during the infusion process.

Buyer Products:

  • ThermaCyl Blood/Fluid Warmer
  
Needleless Fluid Administration/Extension Sets
Valve systems designed to work without needles to prevent patient injuries.

Buyer Products:

  • Clearlink
  • Interlink Luer Lock Injection Site Series
  • Baxject Needleless Transfer Device
  
Pump Sets
Pump sets designed specifically for infusion therapy.

Buyer Products:

  • PCA II Pump Set Series
  • AP II Pump Set Series
  • Flo-Gard 8000 Series
  
Delivery Systems  
Elastomeric Infusors
Infusion delivery system designed for small-volume fluid transmission (home use).

Buyer Products:

  • Intermate Infusor System Series
  • Small Volume Infusor System Series
  • Large Volume Infusor System Series
  
Pumps  
Multiple Channel
Multiple channel pump designed to deliver more than one infusion therapy to patients.

Buyer Products:

  • Flo-Gard Series
  • COLLEAGUE Infusion Pump
  • 6060 Multi-Therapy Infusion Pump
  
Single Channel
Single channel pump designed to deliver only one infusion therapy to patients.

Buyer Products:

  • maxx Infusion System
  • AP II Pain Management Pump
  • Flo-Gard Series
  
Syringe
Syringe used in place of a pump to deliver infusion therapy.

Buyer Products:

  • Auto Syringe Pump
  • PCA II Pain Management Pump
  • Mini-Infuser Syringe Pump Series
  • Syndeo PCA Syringe Pump
  
Integrated/Comprehensive Systems
Complete infusion systems that include pumps, monitoring devices and other accessories.

Buyer Products:

  • Ipump Pain Management System
  
Vascular Access
Extended In Dwelling Catheters  
Central Venous Catheters (CVC)
Catheters designed to handle high volume flow.

Target Products:

  • Antimicrobial Central Venous Cathether (CVC)
  
Peripheral Intravenous Catheters  
Infusion Sets
Complete infusion sets containing peripheral intravenous catheters.

Buyer Products:

  • Sub-Q-Set Subcutaneous Series
  • Micro-Volume Series
  
Standard
Non-ported peripheral intravenous catheters.

Buyer Products:

  • Interlink Flash-Cath Series
  • Interlink Quik-Cath Series
  
Gastroenterology  
Treatment  
Stomach  
Tubes  
Feeding
A tube that carries food to the stomach.

Buyer Products:

  • Clintec Dual Port Feeding Tube Series
  
General Surgery
Invasive
Surgical-Site Treatments
Anti-Adhesives/Anti-Scarring
Gels
Gel-based products applied during interventional procedures to prevent adhesion to medical devices or to prevent scarring of the surgical site

Buyer Products:

  • ADEPT Adhesion Reduction Solution

Target Products:

  • Cohesion Technologies Adhibit Adhesion Prevention Gel
Sealants
Adhesives
Glue based products used to seal tissue during surgical procedures

Target Products:

  • Cohesion Technologies CoSeal Surgical Sealant
  • Cohesion Technologies Internal Adhesives
  
Hemostatic
Delivery Systems
Medical devices designed to deliver hemostatic sealants to the surgical site

Buyer Products:

  • Tissomat Application Device

Target Products:

  • Cohesion Technologies Air Regulator
  • Cohesion Technologies Spray Kit
Hemostats
Instruments designed to close off vessels during surgical procedures.

Target Products:

  • Vitagel
  
Sponges
Microfibrillar sponge used when conventional hemostasis procedures are not effective.

Buyer Products:

  • Fusion Medical FloSeal Sponge
  
Topical
Topical mixture used when conventional hemostasis procedures are not effective.

Buyer Products:

  • Fusion Medical FloSeal Matrix
  • Baxter BioScience Tisseel VH Kit (Two-Component Fibrin Sealant)
  
Medical Supplies  
Diagnostic  
Clinical Examination  
Basic Examining Tools
Medical instruments used to examine and monitor basic physiological functions, such as reflex, blood pressure, heart rate, and pulmonary capacity. These instruments include stethoscopes, sphygmomanometers, percussion hammers and other similar items.

Buyer Products:

  • French Esophageal Stethoscope Series
  
Safety and Sterilization  
Safety  
Waste Management
Products used to control and contain biohazardous materials, such as chemical waste, fluid waste, and solid waste. These products may include bags, containers, and other more advanced waste treatment systems.

Buyer Products:

  • Bentley BosPac Plus
  
Neurology  
Diagnostic  
Monitoring  
Monitors  
Electroencephalograph (EEG)  
Intraoperative
An electroencephalograph that is used during surgery.

Buyer Products:

  • Physiometrix Patient State Analyzer (PSA) 4000
  
Surgical  
General Procedure  
Surgical Sealants
A glue like material, made up of biomaterials, that is used to close up surgical incisions.

Buyer Products:

  • Fusion Medical Proceed
  
Ophthalmology  
Surgical  
Procedure/Region Specific  
Cataract  
Viscoelastics
Material that can be applied to decrease resistance between two parts of the eye and promote healing and repair of damaged eye tissue.

Buyer Products:

  • Hylenex (Recombinant Human Hyaluronidase)
  
Orthopedics
Surgical
Procedure Specific
Bone Loss Reconstruction
General
Bone Fillers
Devices used to fill the formed bone cavity with hardening material.

Buyer Products:

  • Tricos T Bone Void Filler

Target Products:

  • Neucoll Collagraft
  • Neucoll NeuGraft
Plastic/Reconstructive Surgery  
Surgical  
Procedure/Region Specific  
Implants  
Facial  
Sutures
Sutures that are threaded into the face to elevate the midface, brow and neck.

Target Products:

  • Contour Thread
  
Respiratory  
Treatment  
Assisted Breathing  
Intubation  
Breathing Circuits
Instrument used to measure respiratory parameters such as pressure.

Buyer Products:

  • Thick Cuff Adult Series
  • Baxter Latex-Free Breathing Circuits
  • Baxter Standard Adult Breathing Circuits
  • Baxter Pediatric Isoflex Series Breathing Circuit
  • Baxter Pediatric Breathing Circuits
  • Baxter Isoflex Series Breathing Circuits
  
Transfusion Medicine
Blood Collection
Accessories  
Collection/Storage
Devices, usually polymer plastic bags used for collection and subsequent storage of blood and blood components. Specific additives may or may not be incorporated to prevent the collected blood from clotting.

Buyer Products:

  • Cryocyte Freezing Containers
  • Fenwal Blood-Pack Series
  • Fenwal Double Blood-Pack Series
  
Apheresis Systems
Plasma
Systems which separate and collect the plasma component of human blood while returning other blood components to the donor.

Buyer Products:

  • Fenwal Amicus
  • Fenwal Autopheresis-C
  • Fenwal CS-3000 Plus

Target Products:

  • Cohesion Technologies CellPaker
Platelets
Systems which separate and collect the platelet cell component of human blood while returning other blood components to the donor.

Buyer Products:

  • Fenwal Amicus
  
Red Blood Cells
Systems which separate and collect the red cell component of human blood while returning other blood components to the donor.

Buyer Products:

  • Alyx Blood Collection System
  • Fenwal CS-3000 Plus
  
Blood Washers
Instruments used to wash blood cells in preparation for usage; they are often used to prepare frozen red blood cells for transfusion.

Buyer Products:

  • Cytomate Cell Processing System
  
Filtration Systems
Medical devices used to filter leukocytes from blood during the transfusion process.

Buyer Products:

  • Sepacell Leukocyte Reduction Filters
  • Sepacell RZ-2000
  
Viral Inactivation  
Plasma
Medical devices and technology which destroy infectious agents such as viruses in donor plasma without damaging the integrity of the plasma proteins.

Buyer Products:

  • Helinx Intercept Plasma System
  
Platelets
Medical devices and technology which destroy infectious agents such as viruses in blood products (platelets) without damaging the integrity of the donor platelet cells.

Buyer Products:

  • Helinx Intercept Platelet System
  
Red Blood Cells
Medical devices and technology which destroy infectious agents such as viruses in donor blood without damaging the integrity of the donor red blood cells.

Buyer Products:

  • Helinx Intercept Red Blood Cell System
  
Urology
Surgical  
General Procedure  
Minimally Invasive/Cystoscopy  
Irrigation Pumps/Systems
Surgical instruments that pump fluids to irrigate/moisten the surface of the urinary organs

Buyer Products:

  • Irrigation Set Series
  
Treatment
Renal
Hemodialysis
Components
Access Grafts
Pieces of material or tissue used to cover up holes made in the body for hemodialysis access.

Target Products:

  • Vascular Wrap Paclitaxel-Eluting Mesh/Lifespan Vascular Graft
  
Concentrates
Chemicals used in hemodialysis.

Buyer Products:

  • Althin Biopharm
  
Dialysate Parameter Monitors
Medical products used to monitor parameters such as fluid pressure, concentration, pH etc. during dialysis procedures.

Buyer Products:

  • Althin Biopharm Hemavision
  
Filtration  
Dialyzers
The instrument or medium used to effect chemical dialysis which allows for the diffusion of waste products and excess water into a dialysate solution.

Buyer Products:

  • Althin Altrex
  • Althin MCA
  • Accura
  • Althin Altra Flux
  • Althin Altra Nova
  
Hemofilters
Filters used to separate the blood from the waste components during dialysis through a convection process by creating negative pressure to draw out solute particles without using a dialysate solution.

Buyer Products:

  • Renalflo II
  
Systems
A complete set of devices that act as a kidney to remove waste from the circulatory system.

Buyer Products:

  • Althin AltraTouch 1000
  • BM25
  • Arena
  • Althin TINA System 1000 Series
  • Althin System 1000
  • Althin System 1000 with 750 RO Unit
  
Peritoneal Dialysis  
Components  
Solutions
Chemical agents used in peritoneal dialysis.

Buyer Products:

  • Extraneal (Icodextrin)
  • Dianeal Series
  
Systems  
Automated Peritoneal Dialysis (APD)
Complete set of instruments and devices that cycle solution to and from the patient's peritoneum during sleep.

Buyer Products:

  • HomeChoice Pediatric Automated
  • HomeChoice PRO(TM) with PD Link(TM)
  • QUANTUM PD System
  • HomeChoice Automated
  
Continuous Ambulatory (CAPD)
Complete set of instruments and devices that perform peritoneal dialysis that can be moved around with the patient.

Buyer Products:

  • UltraBag System
  
Vascular
Surgical
General Procedure
Accessories  
Vessel Closure
Devices used to close and repair vascular structures, including both complete systems and associated clamps, felts and pledgets.

Buyer Products:

  • Fusion Medical FloSeal FAST
  
Grafts  
Access/Peripheral  
Polytetrafluoroethylene (PTFE)
Surgical grafts made from polytetraflouroethylene (PTFE), a plastic derivative .

Target Products:

  • Lifespan Series
  
Patches  
Polyester/Textile
Surgical patches produced from fabric-based material (polyester/textile) .

Target Products:

  • Vascular Wrap
  
Procedure/Region Specific  
Percutaneous Transluminal Angioplasty (PTA)  
Restenosis Prevention  
Stents Systems  
Peripheral
Stents designed to be placed in peripheral blood vessels.

Target Products:

  • BSC/COOK Zilver PTX Peripheral Stent
  
Nutritional Health  
Dietary/Naturopathic Supplements  
General Health
Products consisting of dietary/naturopathic supplements that are intended to support general health.

Buyer Products:

  • Baxter Inernational Inc.
  
Outsourced Services  
Development/Manufacturing Services  
Contract Manufacturing Organizations (CMO)  
Pharmaceuticals  
Final Dosage Forms
Contract Manufacturing Organizations (CMO) that produce large quantities of drug products in final dosage forms ready to be sold to end users.

Buyer Products:

  • Baxter Bioscience
  
Scientific Products  
Consumables  
Bioanalytical Chemistry  
Cell Biology  
Cell Culture  
Media
Cell biology consumables used for the growth of cells or organs.

Target Products:

  • Cohesion Technologies Cell Prime Collagen In Solution
  • Cohesion Technologies Vitrogen, Collagen In Solution
  

- Focused. Denotes that the company is considered focused in this area. In general, Focused Companies draw the majority of their earnings in the sector/product area specified.

- Sector Pure-Plays. Denotes that the company is focused in the selected sector and generates nearly all earnings in the sector/product area specified.

- Sector Participation. Denotes that the company develops products in this line of business.

Relationship Details

Key Competitors

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Overlap
  Wyeth n/a 68,614.316 16.85 16.22 3.45 3.42 6.53
Cardinal Health, Inc. n/a 28,930.007 19.58 21.55 0.34 0.33 6.41
ThermoGenesis Corp. n/a 224.707 n/a -70.33 15.78 10.17 5.44
Buyer
  Wyeth n/a 68,614.316 16.85 16.22 3.45 3.42 6.53
Bayer AG (ADR) n/a 42,757.177 22.96 16.36 1.12 1.13 n/a
Cardinal Health, Inc. n/a 28,930.007 19.58 21.55 0.34 0.33 6.41
Fresenius Medical Care AG & Co. (ADR) n/a 13,028.861 26.04 23.04 1.65 1.54 n/a
Rexam PLC (ADR) n/a 5,913.710 10.93 14.28 0.85 0.85 n/a
Target
  Johnson & Johnson n/a 191,560.368 17.33 16.97 3.59 3.32 n/a
Novartis AG (ADR) n/a 134,499.467 25.55 17.09 3.66 3.40 3.27
Abbott Laboratories n/a 80,657.105 46.98 18.78 3.59 3.29 n/a
Wyeth n/a 68,614.316 16.85 16.22 3.45 3.42 6.53
Medtronic, Inc. n/a 61,171.208 22.74 22.72 5.18 4.97 14.20
Tyco International Ltd. n/a 61,147.156 16.41 15.14 1.49 1.41 11.25
Alcon, Inc. n/a 35,310.776 33.50 27.74 7.47 7.26 17.30
Baxter International Inc. n/a 31,904.764 22.82 22.76 3.07 3.14 5.09
Cardinal Health, Inc. n/a 28,930.007 19.58 21.55 0.34 0.33 6.41
Boston Scientific Corp. n/a 25,750.098 n/a 22.33 3.53 3.31 n/a
Allergan, Inc. n/a 17,753.715 n/a 31.98 6.28 5.75 114.76
Genzyme Corporation n/a 17,146.072 47.88 29.48 5.60 5.43 5.69
C.R. Bard, Inc. n/a 8,351.929 25.29 21.56 4.36 3.88 n/a
Bausch & Lomb Inc. n/a 2,888.473 19.41 82.00 1.23 1.21 5.06
SurModics, Inc. n/a 581.219 28.90 22.68 8.28 8.16 4.20
Lifecore Biomedical, Inc. n/a 240.201 33.79 28.33 3.64 3.22 2.92
ThermoGenesis Corp. n/a 224.707 n/a -70.33 15.78 10.17 5.44

- Defined by the Company - Defined by Others

Dependent Suppliers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Teva Pharmaceutical Industries Ltd (ADR) n/a 26,348.593 67.39 14.70 3.50 3.12 36.60
Acxiom Corporation n/a 1,757.610 20.08 23.62 1.27 1.21 n/a
TALX Corporation n/a 999.818 30.08 27.91 3.89 3.50 n/a
Angiotech Pharmaceuticals, Inc. (USA) n/a 749.556 n/a 14.77 2.86 2.45 n/a
Ariba, Inc. n/a 714.895 n/a 24.70 2.41 2.28 n/a
Cangene Corporation n/a 635.549 43.19 n/a 6.67 n/a 5.64
Halozyme Therapeutics, Inc. n/a 496.905 n/a -34.14 816.65 681.71 33.01
Capital Lease Funding, Inc. n/a 379.631 89.82 11.79 3.33 3.01 1.22
Dyax Corp. n/a 152.990 n/a -3.63 9.05 11.55 3.69
Cerus Corporation n/a 150.771 n/a -10.52 5.58 5.45 2.06
ZEVEX International, Inc n/a 72.123 16.83 n/a 1.76 n/a 4.48
XATA Corporation n/a 43.272 n/a -47.27 1.41 1.30 8.34
Attunity Ltd n/a 31.263 n/a n/a 2.34 n/a 17.76
MTM Technologies, Inc. n/a 18.582 n/a n/a 0.07 n/a n/a
HEI, Inc. n/a 13.877 n/a n/a 0.27 n/a 1.92
Target
  Orthovita Inc. n/a 208.774 n/a -10.12 4.86 4.35 10.20

- Defined by the Company - Defined by Others

Key Customers

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Medco Health Solutions Inc. n/a 17,092.041 29.55 21.34 0.40 0.40 n/a
MedImmune, Inc. n/a 8,070.858 n/a 262.62 6.51 6.27 8.02
DaVita Inc. n/a 5,387.200 19.26 20.80 1.14 1.12 n/a
Amylin Pharmaceuticals, Inc. n/a 5,048.180 n/a -21.12 12.28 9.99 7.52
MGi Pharma, Inc. n/a 1,504.470 n/a -108.24 4.38 4.17 n/a
United Therapeutics Corporation n/a 1,306.608 27.30 32.03 9.11 8.71 4.94
Allos Therapeutics, Inc. n/a 338.595 n/a -10.84 n/a 32.89 9.96
Acambis plc (ADR) n/a 198.631 n/a -4.40 2.71 3.25 1.99
Cerus Corporation n/a 150.771 n/a -10.52 5.58 5.45 2.06
Cyclacel Pharmaceuticals Inc. n/a 126.194 n/a -3.39 120.90 354.32 2.23
Neurobiological Technologies, Inc. n/a 71.827 n/a -4.98 4.47 4.63 n/a
Praecis Pharmaceuticals n/a 53.114 n/a n/a 11.84 n/a 2.07
Government - Austria n/a n/a n/a n/a n/a n/a n/a
National Health Service (United Kingdom) n/a n/a n/a n/a n/a n/a n/a
Target
  Baxter International Inc. n/a 31,904.764 22.82 22.76 3.07 3.14 5.09

- Defined by the Company - Defined by Others

Key Partners

  Name Dir Percent Market Cap. P/E Ratio (TTM) Fwd P/E P/R Ratio (TTM) Fwd P/Rev Price To Tang. Book Value
Buyer
  Cardinal Health, Inc. n/a 28,930.007 19.58 21.55 0.34 0.33 6.41
Teva Pharmaceutical Industries Ltd (ADR) n/a 26,348.593 67.39 14.70 3.50 3.12 36.60
Medco Health Solutions Inc. n/a 17,092.041 29.55 21.34 0.40 0.40 n/a
Computer Sciences Corporation n/a 9,051.948 20.56 14.43 0.62 0.61 4.23
MedImmune, Inc. n/a 8,070.858 n/a 262.62 6.51 6.27 8.02
DaVita Inc. n/a 5,387.200 19.26 20.80 1.14 1.12 n/a
Amylin Pharmaceuticals, Inc. n/a 5,048.180 n/a -21.12 12.28 9.99 7.52
MGi Pharma, Inc. n/a 1,504.470 n/a -108.24 4.38 4.17 n/a
The Medicines Company n/a 1,490.967 341.56 91.19 8.03 6.76 7.46
Haemonetics Corporation n/a 1,315.038 22.80 26.88 3.02 2.86 3.31
United Therapeutics Corporation n/a 1,306.608 27.30 32.03 9.11 8.71 4.94
Nektar Therapeutics n/a 1,200.029 n/a -10.56 6.64 5.93 7.34
InterMune, Inc. n/a 1,182.244 n/a -17.65 11.82 12.71 n/a
Angiotech Pharmaceuticals, Inc. (USA) n/a 749.556 n/a 14.77 2.86 2.45 n/a
Target
  Baxter International Inc. n/a 31,904.764 22.82 22.76 3.07 3.14 5.09
Boston Scientific Corp. n/a 25,750.098 n/a 22.33 3.53 3.31 n/a
Genzyme Corporation n/a 17,146.072 47.88 29.48 5.60 5.43 5.69
Edwards Lifesciences Corp n/a 2,953.734 19.90 24.71 2.89 2.80 11.06
CombinatoRx, Incorporated n/a 233.961 n/a -6.83 18.01 18.63 2.46
Orthovita Inc. n/a 208.774 n/a -10.12 4.86 4.35 10.20
Poniard Pharmaceuticals Inc. n/a 122.936 n/a n/a 10,780.00 n/a 3.03
University Of British Columbia n/a n/a n/a n/a n/a n/a n/a
Cook Group Inc. n/a n/a n/a n/a n/a n/a n/a
Poly-Med, Inc. n/a n/a n/a n/a n/a n/a n/a
Government - United States n/a n/a n/a n/a n/a n/a n/a

- Defined by the Company - Defined by Others

Financials

  Buyer Target Combined Entity
Income Statement
Operating Items
Revenue 10,378.0 261.7 10,639.7
Other Revenue 0.0 0.0 0.0
Total Revenue 10,378.0 261.7 10,639.7
Cost of Revenue 5,641.0 72.0 5,713.0
SG&A Expense 2,282.0 54.9 2,336.9
Depreciation & Amortization 0.0 27.0 27.0
Research & Development 614.0 41.9 655.9
Interest Expense 0.0 0.0 0.0
Other Operating Expense 0.0 0.0 0.0
Unusual Expense (Income) 0.0 65.4 65.4
Total Expenses 8,537.0 261.3 8,798.3
Operating Income 1,841.0 0.4 1,841.4
Non Operating Items
Interest Expense (Inc.), Net Non-Oprtng -33.0 -21.7 -54.7
Gain/Loss On Sale Of Assets 0.0 -0.4 -0.4
Other, Net -62.0 8.1 -53.9
Income Before Taxes 1,746.0 -13.6 1,732.4
Income Taxes 348.0 10.9 358.9
Income After Taxes 1,398.0 -24.5 1,373.5
Net Income - Excl. Xord. Items 1,398.0 -24.5 1,373.5
Discontinued Operations 0.0 -10.9 -10.9
Accounting Change 0.0 0.4 0.4
Net Income - Incl. Xord. Items 1,398.0 -35.0 1,363.0
Income Avail. to Common 1,398.0 -35.0 1,363.0
Share Items
Basic Avg. Shares Outstanding 651.0 84.8 735.8
Basic EPS - Excl. Xord. Items 2.15 n/a 1.87
Basic EPS - Incl. Xord. Items 2.15 n/a 1.85
Full Dilution Adjustment 0.0 0.0 0.0
Fully Diluted Shares Outstanding 656.0 85.5 741.5
F.D. EPS - Excl. Xord. Items 2.13 n/a 1.85
F.D. EPS - Incl. Xord. Items 2.13 n/a 1.84
Balance Sheet
Assets
Cash and Equivalents 2,485.0 81.7 2,566.7
ST Investments 0.0 8.0 8.0
Accounts Receivable 1,838.0 24.7 1,862.7
Inventory 2,066.0 31.6 2,097.6
Prepayments and Advances 0.0 5.2 5.2
Other Current Assets 581.0 22.0 603.0
Current Assets 6,970.0 173.1 7,143.1
PPE 0.0 72.4 72.4
Accum D&A 0.0 -11.8 -11.8
PPE, Net 4,229.0 60.6 4,289.6
Goodwill & Intangibles 0.0 894.0 894.0
Long Term Investments 0.0 43.3 43.3
Other Assets 0.0 0.0 0.0
Other LT Assets 3,487.0 23.4 3,510.4
Total Assets 14,686.0 1,194.4 15,880.4
Liabilities
Accounts Payable 0.0 9.5 9.5
Payable/Accrued 3,376.0 0.0 3,376.0
Accrued Expenses 0.0 30.2 30.2
ST Debt 234.0 0.0 234.0
Curr Port of LTD & Cap Lease Oblg 0.0 3.2 3.2
Other (Current) Liabilities 0.0 22.9 22.9
Current Liab. 3,610.0 65.9 3,675.9
LT Debt 2,567.0 566.7 3,133.7
Total LT Debt 2,567.0 566.7 3,133.7
Deferred Taxes 0.0 72.4 72.4
Other LT Liab. 2,237.0 4.2 2,241.2
Total Liabilities 8,414.0 709.1 9,123.1
Shareholders Equity
Common Stock 0.0 470.1 470.1
Additional Paid in Capital 0.0 26.3 26.3
Retained Earnings 0.0 -29.3 -29.3
Other Equity 6,272.0 18.1 6,290.1
Total Equity 6,272.0 485.3 6,757.3
Total Liab. & Equity 14,686.0 1,194.4 15,880.4
Shares Outstanding 651.0 85.0 736.0
Cash Flow
Operating Cash Flow
CF Net Income n/a -42.5 -42.5
CF Depreciation n/a 25.7 25.7
CF Deferred Taxes n/a -25.8 -25.8
Other Non-Cash Items n/a 73.6 73.6
Change in Working Capital n/a 15.9 15.9
Total Cash From Operating Activities n/a 47.0 47.0
Investing Cash Flow (not calculated)
Capital Expenditures n/a -11.2 -11.2
Other Investing Cash Flows n/a -78.0 -78.0
Total Cash From Investing Activities n/a -89.1 -89.1
Financing Cash Flow (not calculated)
Dividends Paid n/a 0.0 0.0
Purchase Or Sale of Stock n/a 4.9 4.9
Purchase and Retirement of Debt n/a -35.5 -35.5
Other Financing Cash Flow n/a 0.0 0.0
Total Cash From Financing Activities n/a -30.6 -30.6
Exchange Rate Effects n/a 0.0 0.0
Net Change in Cash n/a -72.8 -72.8
Cash Taxes Paid n/a 15.8 15.8